Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideMRKMerck & Co.
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | MRK | TMO |
|---|
| Close | 149.52 | 697.00 |
| Market Cap | $371B | $258B |
| 1M | +2.90% | +3.25% |
| P/E (TTM) | 117.2 | 36.4 |
| Forward P/E | 19.6 | 24.6 |
| P/E 5-Yr Percentile | 81 | 78 |
| P/S | 5.6 | 5.4 |
| P/B | 8.9 | 4.7 |
| Dividend Yield | 2.87% | 0.29% |
| Latest Quarter Revenue | $16.6B | $12.1B |
| Revenue YoY | +5.1% | +9.1% |
| Gross Margin | 73.5% | — |
| Latest Quarter EPS | -0.54 | 4.64 |
| Avg Post-Earnings Move | ±1.7% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.37% | 1.82% |
| 90-Day Net Insider Buying | −$30.0M | −$40.3M |
MRK · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
